# Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)

> **NCT04175132** · PHASE1 · TERMINATED · sponsor: **H. Lundbeck A/S** · enrollment: 6 (actual)

## Conditions studied

- Healthy
- Parkinson Disease

## Interventions

- **DRUG:** foliglurax
- **DRUG:** foliglurax

## Key facts

- **NCT ID:** NCT04175132
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-12
- **Primary completion:** 2020-03-03
- **Final completion:** 2020-03-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** New efficacy data from another study
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175132, "Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04175132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*